Cystatin C and preclinical lesions in the target organs of hypertensive patients
AIM. To study the association between cystatin C levels and preclinical lesions in the target organs (heart, kidney, vessels) of patients with hypertensive disease (HD) at moderate and high risks for cardiovascular events (CVE). MATERIALS AND METHODS. The investigation enrolled 47 patents (30 men an...
Main Authors: | E V Oshchepkova, V A Dmitriev, V N Titov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
"Consilium Medicum" Publishing house
2014-09-01
|
Series: | Терапевтический архив |
Subjects: | |
Online Access: | https://ter-arkhiv.ru/0040-3660/article/view/31545 |
Similar Items
-
Cystatin C and uncontrolled hypertension
by: Mehmet Onur Omaygenç, et al.
Published: (2020-10-01) -
Cystatin C and chronic kidney disease in children
by: S.V. Kushnirenko, et al.
Published: (2017-10-01) -
Study of serum cystatin C levels in patients with obstructive sleep apnea
by: Eman Elfeky, et al.
Published: (2019-10-01) -
Cystatin C: Renal function and cardiovascular risk
by: Wagner Carola
Published: (2008-01-01) -
Cystatin C is a new marker for left ventricular hypertrophy in patients with chronic kidney disease
by: M P Vasilyeva, et al.
Published: (2015-06-01)